Alison Brind

1.0k total citations
10 papers, 236 citations indexed

About

Alison Brind is a scholar working on Surgery, Hepatology and Pharmacology. According to data from OpenAlex, Alison Brind has authored 10 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Hepatology and 3 papers in Pharmacology. Recurrent topics in Alison Brind's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Alison Brind is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Alison Brind collaborates with scholars based in United Kingdom, Australia and France. Alison Brind's co-authors include C. Bréchot, Jiaji Jiang, Dina Kremsdorf, Didier Samuel, Cyrille Féray, M. Gigou, Adam D. Farmer, Ian Gilmore, Adam Hurlstone and Neil Fisher and has published in prestigious journals such as Journal of Hepatology, Alcohol and Alcoholism and Drug and Alcohol Review.

In The Last Decade

Alison Brind

10 papers receiving 230 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Brind United Kingdom 6 145 130 42 32 23 10 236
Yuan-Jen Wang Taiwan 9 180 1.2× 224 1.7× 37 0.9× 27 0.8× 30 1.3× 17 321
Luiz Carlos da Costa Gayotto Brazil 9 199 1.4× 280 2.2× 46 1.1× 44 1.4× 15 0.7× 22 359
Alisa Likhitsup United States 9 132 0.9× 158 1.2× 43 1.0× 29 0.9× 15 0.7× 32 252
Yuji Kojima Japan 7 127 0.9× 143 1.1× 29 0.7× 25 0.8× 11 0.5× 16 253
H Labadie France 9 106 0.7× 136 1.0× 73 1.7× 15 0.5× 26 1.1× 20 247
Xaralambos Zervos United States 8 225 1.6× 166 1.3× 47 1.1× 34 1.1× 29 1.3× 22 328
Irene Vafiadis Greece 9 235 1.6× 246 1.9× 128 3.0× 39 1.2× 26 1.1× 11 379
Yoichi Sameshima Japan 9 74 0.5× 122 0.9× 20 0.5× 27 0.8× 10 0.4× 15 255
Robert Tidswell United Kingdom 8 105 0.7× 111 0.9× 54 1.3× 44 1.4× 29 1.3× 10 250
Sagnik Biswas India 9 83 0.6× 104 0.8× 43 1.0× 20 0.6× 27 1.2× 62 233

Countries citing papers authored by Alison Brind

Since Specialization
Citations

This map shows the geographic impact of Alison Brind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Brind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Brind more than expected).

Fields of papers citing papers by Alison Brind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Brind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Brind. The network helps show where Alison Brind may publish in the future.

Co-authorship network of co-authors of Alison Brind

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Brind. A scholar is included among the top collaborators of Alison Brind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Brind. Alison Brind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wessels, Julie, et al.. (2016). Plasmapheresis in management of severe cholestasis of pregnancy. 2. 14–19. 2 indexed citations
2.
Farmer, Adam D. & Alison Brind. (2011). Drug-induced liver injury. Medicine. 39(9). 536–540. 18 indexed citations
3.
Brind, Alison. (2006). Drugs that damage the liver. Medicine. 35(1). 26–30. 29 indexed citations
4.
Brind, Alison, Adam Hurlstone, Ian Gilmore, et al.. (2004). THE ROLE OF POLYMORPHISMS OF GLUTATHIONE S-TRANSFERASES GSTM1, M3, P1, T1 AND A1 IN SUSCEPTIBILITY TO ALCOHOLIC LIVER DISEASE. Alcohol and Alcoholism. 39(6). 478–483. 39 indexed citations
5.
Brookes, Matthew & Alison Brind. (2003). Coin ingestion, an unexpected finding at colonoscopy: case report.. PubMed. 5(1). 8–8. 3 indexed citations
6.
Brind, Alison. (2002). Drugs that Damage the Liver. Medicine. 30(11). 21–23. 2 indexed citations
7.
Jeffrey, Gary P., Alison Brind, Donald Ormonde, et al.. (1999). MANAGEMENT OF BILIARY TRACT COMPLICATIONS FOLLOWING LIVER TRANSPLANTATION. Australian and New Zealand Journal of Surgery. 69(10). 717–722. 31 indexed citations
8.
Serfaty, Marc, Andrew Lawrie, Belinda Smith, et al.. (1997). Risk factors and medical follow‐up of drug users tested for hepatitis C—can the risk of transmission be reduced?. Drug and Alcohol Review. 16(4). 339–347. 26 indexed citations
9.
Brind, Alison, Jiaji Jiang, Didier Samuel, et al.. (1997). Evidence for selection of hepatitis B mutants after liver transplantation through peripheral blood mononuclear cell infection. Journal of Hepatology. 26(2). 228–235. 85 indexed citations
10.
Brind, Alison, et al.. (1991). Alpha-1-antitrypsin genotype — A risk factor for alcoholic cirrhosis?. Journal of Hepatology. 13. S14–S14. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026